Gene list for bulk-seq and cell-type-specific DEGs.
收藏NIAID Data Ecosystem2026-03-13 收录
数据链接：
官方服务：
资源简介：
SMA vs. control. (XLSX)
应用场景：
创建时间：
2022-09-08
相关数据集
Gene expression profiling in a VRK1 R358X homozygote patient
VRK1 mutations in humans cause a severe neuronal phenotype includung spinal muscular atrophy (SMA) and microcephaly. To study the effect of VRK1 R358X mutation on global gene expression in a homozygot
NIAID Data Ecosystem80
Therapeutic strategy for spinal muscular atrophy by combining gene supplementation and genome editing. Therapeutic strategy for spinal muscular atrophy by combining gene supplementation and genome editing
Defect in the SMN1 gene causes spinal muscular atrophy (SMA), which shows loss of motor nerve cells, muscle weakness and atrophy. While current treatment strategies including small molecules or viral
NIAID Data Ecosystem50
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers
Small molecule splicing modifiers have been extensively described which target the generic splicing machinery and thus have low target specificity. We have identified potent splicing modifiers with un
NIAID Data Ecosystem40
Canine DUXC isoforms and functional similarity to human DUX4 [RNA-seq]
Human DUX4 and mouse Dux transcription factors are normally expressed in the germ line and early embryonic cells where they activate the cleavage stage genes. The misexpression of DUX4 in skeletal mus
NIAID Data Ecosystem50
DMD and SMA sequencing
An MLPA based next generation sequencing assay has been developed that allows high throughput screening for a large number of fragments and samples suspected with DMD or SMA by integrating additional
NIAID Data Ecosystem50
